Stocks · News reference
DocGo Narrows FY2026 Sales Guidance from $300.000M-$315.000M to $305.000M-$310.000M vs $306.281M Est
DocGo (NASDAQ:DCGO) narrows FY2026 sales outlook from $300.000 million-$315.000 million to $305.000 million-$310.000 million vs $306.281 million estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 17, 2026, 8:23 PM
- Checked
- Aug 17, 2026, 8:23 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Needham Reiterates Buy on DocGo, Maintains $3 Price Target
Needham analyst Ryan MacDonald reiterates DocGo (NASDAQ:DCGO) with a Buy and maintains $3 price target.
Read original at benzingaTranscript: DocGo Q2 2026 Earnings Conference Call
DocGo (NASDAQ:DCGO) reported second-quarter financial results on Monday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Read original at benzinga12 Health Care Stocks Moving In Monday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) stock moved upwards by 13.1% to $1.73 during Monday's after-market session. The company's market cap stands at $1.7 million. The company's, Q2 earnings came out today.
Read original at benzinga